Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2021-09-20 00:00:00 ET · period of report 2021-09-16 · accession 0001213900-21-048832 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-20 | 2021-09-16 | ORMP | RAKIN KEVIN | Dir | S - Sale | $20.99 | -21.1K | 57.0K | -27% | -$442.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-16 | S | D | 21,100 | $20.99 | 57,004 | D | — | — |